SELLAS Life Sciences Group Inc. (NASDAQ:SLS) reported first-quarter (Q1) 2026 financial results on Tuesday while highlighting progress across its acute myeloid leukemia (AML) pipeline. CEO Angelos Stergiou said the company continued advancing its clinical programs during t
Peyto Exploration & Development (PEY:CA) declares CAD 0.12/share monthly dividend, an increase by 9% from the prior CAD 0.11. - Payable June 15; for shareholders of record May 31; ex-div May 31. - See PEY:CA Dividend Scorecard, Yield Chart, & Dividend Growth
RTB Digital, Inc. (NASDAQ: RTB) announced today the successful closing of its merger with RYVYL Inc. (NASDAQ: RVYL), and the commencement of trading of the combined company’s common stock on the Nasdaq Capital Market. RTB is the world’s only full-stack enterprise media pla
Shares of Wix.com (WIX) slumped about 30% on Wednesday after first quarter results missed analysts' estimates. Q1 Metrics The Israel-based web development company's first quarter non-GAAP EPS slumped about 56% year-over-year to $0.68, while revenue jumped 14% year-over-yea
Eric Singer, Director at A10 Networks (NYSE:ATEN), reported the open-market sale of 24,698 shares of common stock on May 5, 2026, according to a SEC Form 4 filing. Transaction summary Transaction and post-transaction values based on SEC Form 4 weighted average price of the
TTEC (TTEC) shares edged up 5% during early market action on Wednesday after securing a strategic collaboration agreement with Amazon Web Services (AMZN) to speed up Amazon Connect adoption with AI-powered customer support. Amazon Connect provides businesses with the abili
BOE Monetary Policy Committee member Mann is speaking and says: Recent geopolitical events have reinforced how exposed the UK economy is to international shocks that require a policy response. Implications of new sources of finance for the UK current account deficit are no
Boston Pizza Royalties Income Fund press release (BPZZF): Q1 GAAP EPS of $0.57. - Revenue of $12.68M. - Cash flows generated from operating activities of $9.6 million for the Period, representing an increase of 3.5% versus the same period one year ago. - Distributable
PDS Biotech targets an interim progression-free survival readout in its Phase 3 trial with around 250 patients enrolled. PDS Biotechnology Corporation has amended its VERSATILE-003 Phase 3 trial to include an interim analysis of progression-free survival (PFS). The trial n
The engineering group confirmed its 2026 outlook after posting stronger-than-expected first-quarter results. Bilfinger reported Q1 non-GAAP earnings per share of $1.04 and revenue of $1.31 billion, up 4% year-over-year. The results exceeded expectations as the company bene